Angiogenic factors in the perinatal period: Diversity in biological functions reflected in their serum concentrations soon after birth

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 169-173

  Malamitsi Puchner, Ariadne ^a   Tziotis, John ^a   Protonotariou, Efthimia ^a   Sarandakou, Angeliki ^a   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

CONFERENCE PAPER; ENZYME IMMUNOASSAY; FEMALE; FETUS; HUMAN; MALE; MATERNAL SERUM; MOTHER; NEWBORN; NORMAL HUMAN; PERINATAL PERIOD; PLACENTA; SERUM; UMBILICAL CORD;

EID: 0034094063     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06227.x     Document Type: Conference Paper

References (13)

1. 1. FOLKMAN, J. & M. KLAGSBRUN. 1987. Angiogenic factors. Science 235: 442-447.
2. 2. GORDON, J.D., J.L. SHIFREN, R.A. FOULK, et al. 1995. Angiogenesis in the human female reproductive tract. Obstet. Gynecol. Surv. 50: 688-697.
3. 3. BECK, L. JR. & P.A. D'AMORE. 1997. Vascular development: cellular and molecular regulation. FASEB J. 11: 365-373.
4. 4. JACKSON, J.R., M.P. SEED, C.H. KIRCHER, et al. 1997. The codependence of angiogenesis and chronic inflammation. FASEB J. 11: 457-465.
5. 5. SHARKEY, A.M., D.S. CHARNOCK-JONES, C.A. BOOCOCK, et al. 1993. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil. 99: 609-615.
6. 6. JACKSON, D., O.V. VOLPERT, N. BOUCK et al. 1994. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266: 1581-1584.
7. 7. SHAPIRO, R. & B.L. VALLEE. 1987. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. USA 84: 2238-2241.
8. 8. MALAMITSI-PUCHNER, A., A. SARANDAKOU, G. GIANNAKI, et al. 1997. Changes of angiogenin serum concentrations in the perinatal period. Pediatr. Res. 41: 909-911.
9. 9. MALAMITSI-PUCHNER, A., J. TZIOTIS, E. PROTONOTARIOU, et al. 1999. Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life. Pediatr. Res. 45: 877-880.
10. 10. SHALABY, F., J. ROSSANT, T.P. YAMAGUCHI, et al. 1995. Failure of blood-island formation and vasculogenesis in FLK-1-deficient mice. Nature 376(6535): 62-66.
11. 11. FERRARA, N., K. HOUCK, L. JAKEMAN & D.W. LEUNG. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev. 13: 18-32.
12. 12. BERSE, B., L.F. BROWN, L. VAN DE WATER, et al. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell 3(2): 211-220.
13. 13. FERRARA, N. & B. KEYT. 1997. Vascular endothelial growth factor: basic biology and clinical implications. EXS 79: 209-232.